This website uses cookies to enhance the user experience.
||
Z

ZYM HOLDING AS989 264 133

Research
Limited company
Tveiteråsvegen 28 5232 PARADIS, Norge

ZYM HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
19 years
since Feb 13, 2006
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1,200,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
64,100
NOK
Annual total result 2024
-116,099
NOK
Total equity 2024
2,605,693
NOK
Last update: Aug 25, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly
Alternate Member-

Others

NameRoleShares
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1,200,000
100 %

Shares owned by the ZYM HOLDING AS

NameShare classTotal number of sharesShare
F
FARMLEC AS
Ordinary shares
14,400
48 %
L
LEUKOLECT AS
Ordinary shares
8,584
37 %
A
AQUAZYME TECHNOLOGY AS
Ordinary shares
36,820
36.82 %
F
FISHLEC AS
Ordinary shares
7,951
24.41 %
A
AQUA BIO TECHNOLOGY ASA
NO0010307135
6
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
64,100
76,800
13,496
101,396
Annual Total Result
-116,099
31,988
-34,048
-380,162
Total assets
2,641,909
2,731,376
2,689,325
2,737,155
Total liabilities
36,215
9,583
66,505
80,286
Total equity
2,605,693
2,721,792
2,622,821
2,656,869

P&L

Year2024202320222021
Total operating income
64,100
76,800
13,496
101,396
Total operating costs
179,946
45,103
48,025
481,891
Operating result
-115,846
31,697
-34,529
-380,495
Financial income/costs
-253
291
481
333
Profit before tax
-116,099
31,988
-34,048
-380,162
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
-116,099
31,988
-34,048
-380,162

Balance overview

Year2024202320222021
Total fixed assets
1,546,256
1,591,355
1,602,439
1,613,524
Total current assets
1,095,653
1,140,021
1,086,886
1,123,631
Total assets
2,641,909
2,731,376
2,689,325
2,737,155
Short term debt
36,215
9,583
66,505
80,286
Long term debt
0
0
0
0
Total liabilities
36,215
9,583
66,505
80,286
Contributed capital
1,200,000
1,200,000
1,200,000
1,200,000
Retained earnings
1,405,693
1,521,792
1,422,821
1,456,869
Total equity
2,605,693
2,721,792
2,622,821
2,656,869
Total equity and liabilities
2,641,908
2,731,376
2,689,325
2,737,155

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology